.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Fish and Richardson
Cantor Fitzgerald
Healthtrust
Mallinckrodt
Novartis
Harvard Business School
Fuji
Express Scripts
Julphar

Generated: September 25, 2017

DrugPatentWatch Database Preview

Sacrosidase - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sacrosidase and what is the scope of sacrosidase freedom to operate?

Sacrosidase
is the generic ingredient in one branded drug marketed by Qol Medcl and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Sacrosidase has three patent family members in three countries.

One supplier is listed for this compound.

Summary for Generic Name: sacrosidase

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list1
Therapeutic Class:Enzyme Replacements/Modifiers
Drug Prices:see low prices
DailyMed Link:sacrosidase at DailyMed

Pharmacology for Ingredient: sacrosidase

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Qol Medcl
SUCRAID
sacrosidase
SOLUTION;ORAL020772-001Apr 9, 1998RXYesYes► Subscribe► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: sacrosidase

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,255,261Ultrapure hypoallergenic solutions of sacrosidase► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: sacrosidase

Country Document Number Estimated Expiration
European Patent Office3102228► Subscribe
Canada2938733► Subscribe
World Intellectual Property Organization (WIPO)2015120284► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Chinese Patent Office
Chubb
Cipla
QuintilesIMS
Daiichi Sankyo
AstraZeneca
Fuji
Merck
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot